9 peptides from her-2/neu, cea, & cta
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2009 (NCT00892567)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- 9 peptides from her-2/neu, cea, & cta
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01532960 | Phase 1 | Jul 1, 2012 | University of Virginia |
| NCT00892567 | Phase 1 | May 1, 2009 | National Cancer Institute (NCI), University of Virginia |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Virginia | Academic/Hospital | 2 | 2 | 1 | 2009 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2009 |
2 organizations
Page 1 / 1